IGC PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
IGC PHARMA, INC. (IGC) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 5.06 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 5.06M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 5.16M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 6.15M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 6.49M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2026-06-30 | 5.06M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 5.16M shares 10-Q · filed 2026-05-15 |
| 2025-12-31 | 6.15M shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 6.49M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 6.50M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 5.80M shares 10-KT · filed 2026-03-18 |
| 2024-12-31 | 7.27M shares 10-Q · filed 2025-02-14 |
| 2024-09-30 | 7.35M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 7.35M shares 10-Q · filed 2024-08-07 |
| 2024-03-31 | 7.45M shares 10-K · filed 2025-06-27 |
| 2023-12-31 | 8.53M shares 10-Q · filed 2024-02-14 |
| 2023-09-30 | 8.53M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 8.54M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 4.43M shares 10-K · filed 2024-06-24 |
| 2022-12-31 | 5.79M shares 10-Q · filed 2023-02-14 |
| 2022-09-30 | 5.79M shares 10-Q · filed 2022-11-01 |
| 2022-06-30 | 5.92M shares 10-Q · filed 2022-08-05 |
| 2022-03-31 | 5.28M shares 10-K · filed 2023-07-07 |
| 2021-12-31 | 5.83M shares 10-Q · filed 2022-02-10 |
| 2021-09-30 | 1.83M shares 10-Q · filed 2021-10-29 |
| 2021-06-30 | 173.00K shares 10-Q · filed 2021-08-11 |
| 2021-03-31 | 173.00K shares 10-K · filed 2022-06-23 |
| 2020-12-31 | 1.83M shares 10-Q · filed 2021-02-16 |
| 2020-09-30 | 1.81M shares 10-Q · filed 2020-11-20 |
| 2020-06-30 | 1.78M shares 10-Q · filed 2020-08-19 |
| 2020-03-31 | 1.85M shares 10-K · filed 2021-06-14 |
| 2019-03-31 | 1.75M shares 10-K · filed 2020-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |